OptoBioMed Co., Ltd. released skin self-diagnosis application “Smart-DermaVision”

WONJU--(Korea Newswire)--OptoBioMed Co., Ltd. (CEO, Byung Sam Jung, www.optobiomed.co.kr), a company specialized in the field of digital imaging processing, has developed and completed the test of the skin self-diagnosis application using smartphone “Smart-DermaVision”, and the company has been providing the service of “Smart-DermaVision” application in English and Korean version.

“Smart-DermaVision” application is an application to analyze the status of skin through the skin picture taken by a smartphone anytime anywhere; thus, it has the advantage of receiving consultations for skin with specialists in conjunction with the hospitals, which are equipped with DermaVision for hospital use.

It is possible to verify the status of skin using the 256 color bars with the pigmentation state of melanin and erythema that are skin pigments through a smartphone screen. With the color bar being closer to blue in the analysis screen, better the status of skin is. On the other hand, closer to yellow/red, worse the status of skin is.

It is also possible to verify the pigmentation and skin tone as well as the analysis of the dark brown areas of skin such as freckle, birthmark, dark circle, blemish, etc. and the red areas of skin such as acne, flush, red spot, etc. when using the status of melanin and erythema and the function of S-Gray (Special Gray).

In addition, it is possible to know the information of skin status and the adequate treatment information for each skin disease through providing the function of result viewing and storing of recorded and analyzed images and the function of searching the hospitals equipped with DermaVision for hospital use and skin information; thus, it is possible to find the description of DermaVision system for hospital use and the hospitals equipped with it.

DermaVision System for hospital use, the skin imaging analysis equipment developed by OptoBioMed Co., Ltd., has been developed as a product for hospital use first to compare and analyze conveniently in a consultation before and after a skin-related treatment of patients such as freckle, blemish, pigmentation, acne, pore, wrinkle, etc. using the digital camera.

This system is being utilized in the dermatology clinics of more than 330 university hospitals with the advantage of convenience of storing, managing and images oanalyzing as well as transferring images through the hospital network. Also it is a product to be exported.

Moreover, OptoBioMed Co., Ltd. plans to provide the service in November upon completion of development of professional skin analyzer application for iPad (iPad-DermaVision) based on Hospital-DermaVision system. It may be used in beauty salons, cosmetics skin shops for skin professional use.

“We expect to create new businesses through developing the customized application using a variety of smartphones and tablet PCs (iPad and Galaxy Tab) as determining the customers’ needs based on our development experience of the skin images diagnosis system (DermaVision for hospital use) for the past nine years in the medical equipment market that has recently been in economic downturn,” CEO Byung Sam Jung said. “Going forward, we will embark on the business to integrate the medical imaging system with a variety of applications.” (Inquirie: +82-33-742-6015)

This is a news release distributed by Korea Newswire on behalf of this company.